Rabeprazole 20mg Gastro-resistant Tablets are indicated for the treatment of: • Active duodenal ulcer • Active benign gastric ulcer • Symptomatic erosive or ulcerative gastro-oesophageal reflux disease (GORD). • Gastro-Oesophageal Reflux Disease Long-term Management (GORD Maintenance) • Symptomatic treatment of moderate to very severe gastro-oesophageal reflux disease (symptomatic GORD) • Zollinger-Ellison Syndrome • In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori in patients with peptic ulcer disease. See section 4.2